Neurologia
Lançamento do primeiro posicionamento científico da OMS sobre melhora da saúde cerebral ao longo da vida.
22 Ago, 2022 | 16:18hComunicado de imprensa: Launch of first WHO position paper on optimizing brain health across life – World Health Organization
Posicionamento científico da OMS: Optimizing brain health across the life course – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
Optimizing #BrainHealth 🧠
▶️reduces the burden of neurological disorders
▶️improves mental + physical health
▶️creates positive social & economic impactscontributing to greater well-being, advancing society. 👉https://t.co/kVPgcFxBPG
— World Health Organization (WHO) (@WHO) August 9, 2022
Estudo randomizado | Efeito do condicionamento isquêmico remoto vs. cuidado usual da função neurológica de pacientes com AVC isquêmico agudo moderado.
22 Ago, 2022 | 16:10hEffect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke: The RICAMIS Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Remote Ischemic Conditioning: Feasible and Potentially Beneficial for Ischemic Stroke – JAMA (gratuito por tempo limitado)
Resumo em vídeo: Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke – JAMA
Estudo sugere que os sintomas da Covid longa afetem 1 em cada 8 pacientes.
22 Ago, 2022 | 14:59hComunicado de imprensa: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet
Comentários:
Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP
Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ
Encefalite paraneoplásica: abordagem clínica para diagnóstico e tratamento.
22 Ago, 2022 | 14:36h
M-A | Efeito da anestesia regional sobre o delirium pós-operatório.
22 Ago, 2022 | 14:26h
Revisão | Cefaleia da COVID longa.
16 Ago, 2022 | 13:03hLong COVID headache – The Journal of Headache and Pain
Comentário no Twitter
#Headache is among the most frequent symptoms persisting or newly developing after #coronavirus disease 2019 (COVID-19) as part of the so-called long #COVID syndrome. Learn more: https://t.co/v1V2jZBluq pic.twitter.com/X6eAgaOaBF
— European Headache Federation (@EHF_Official) August 4, 2022
Sob licença de http://creativecommons.org/licenses/by/4.0/
Estudo randomizado | Um pequeno estudo avaliou a segurança e a eficácia do levetiracetam profilático para prevenção de convulsões epilépticas na fase aguda da hemorragia intracerebral.
16 Ago, 2022 | 12:45hSafety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Neurology (link para o resumo – $ para o texto completo)
Comentário no Twitter (fio – clique para saber mais)
Small study that is not powered to answer this question but raises an interesting ❓ nonetheless: should we use prophylactic antiseizure 💊in #ich? Most recently updated guidelines recommend against this practice. https://t.co/NH45OCtzvv
— Richard Choi, DO (@rkchoi) August 11, 2022
Estudo de coorte | Análise de características clínicas, testes diagnósticos e biomarcadores em pacientes com suspeita de doença de Creutzfeldt-Jakob.
16 Ago, 2022 | 12:37h
Comentário no Twitter
In patients with suspected Creutzfeldt-Jakob disease, CSF RT-QuIC, CSF T-tau, and stereotyped MRI anomalies were associated with diagnosis; myoclonus, stereotyped EEG anomalies, and CSF protein 14-3-3 were less helpful. #CohortStudy https://t.co/w3iaHMj3co
— JAMA Network Open (@JAMANetworkOpen) August 3, 2022
Recomendações internacionais de consenso para manejo do estado epiléptico refratário de início recente incluindo síndrome epiléptica febril relacionada a infecção.
15 Ago, 2022 | 13:31h
Podcast | Dicas sobre esclerose múltipla para o clínico geral.
15 Ago, 2022 | 13:22h#344 Multiple Sclerosis with Dr. Annette Okai – The Curbsiders